TIEN MA: Open Payments
NPI 1962982405 · ANNANDALE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,618 in 59 payments from 17 companies in 2025. Trend: 2023 $1,521 · 2024 $2,598 · 2025 $1,618
Food & beverage: $1,618
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $333 |
| Novo Nordisk Inc | 5 | $209 |
| Gilead Sciences, Inc. | 8 | $207 |
| AstraZeneca Pharmaceuticals LP | 10 | $196 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| PFIZER INC. | 5 | $120 |
| Amgen Inc. | 4 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $70 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Exact Sciences Corporation | 2 | $38 |
Products named: QULIPTA, Ozempic, REXULTI, ELIQUIS, BREZTRI, FARXIGA, Kerendia, OTEZLA.
Industry payments across VA — which companies pay providers there.
